(0.27%) 5 536.50 points
(0.21%) 39 550 points
(0.31%) 19 989 points
(0.65%) $82.07
(-1.96%) $2.55
(0.27%) $2 345.90
(0.10%) $29.59
(-0.57%) $996.20
(-0.24%) $0.931
(-0.27%) $10.65
(-0.15%) $0.790
(1.95%) $87.40
Live Chart Being Loaded With Signals
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific...
Stats | |
---|---|
Šios dienos apimtis | 3.45M |
Vidutinė apimtis | 5.29M |
Rinkos kapitalizacija | 37.72B |
EPS | $4.60 ( Q1 | 2024-03-31 ) |
Kita pelno data | ( $0.0900 ) 2024-08-07 |
Last Dividend | $0.106 ( 2024-03-14 ) |
Next Dividend | $0 ( N/A ) |
P/E |
27.53 (Sector) 49.64 (Industry) 35.32 |
ATR14 | $0.00700 (0.08%) |
Tūris Koreliacija
Haleon plc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Haleon plc Koreliacija - Valiuta/Žaliavos
Haleon plc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $11.30B |
Bruto pelnas: | $6.96B (61.60 %) |
EPS: | $0.110 |
FY | 2023 |
Pajamos: | $11.30B |
Bruto pelnas: | $6.96B (61.60 %) |
EPS: | $0.110 |
FY | 2022 |
Pajamos: | $10.86B |
Bruto pelnas: | $6.58B (60.57 %) |
EPS: | $0.110 |
Financial Reports:
No articles found.
Haleon plc Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0577 (N/A) |
$0 (N/A) |
$0.0460 (N/A) |
$0 (N/A) |
$0.106 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0577 | 2023-03-16 |
Last Dividend | $0.106 | 2024-03-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-05-16 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.210 | -- |
Avg. Dividend % Per Year | 1.30% | -- |
Score | 2.11 | -- |
Div. Sustainability Score | 1.333 | |
Div.Growth Potential Score | 2.42 | |
Div. Directional Score | 1.876 | -- |
Year | Amount | Yield |
---|---|---|
2023 | $0.104 | 1.31% |
2024 | $0.106 | 1.29% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
14 Mar 2024 | $0.106 | 29 Feb 2024 | 15 Mar 2024 | 16 May 2024 |
24 Aug 2023 | $0.0460 | 02 Aug 2023 | 25 Aug 2023 | 05 Oct 2023 |
16 Mar 2023 | $0.0577 | 02 Mar 2023 | 17 Mar 2023 | 27 Apr 2023 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ECC | Dividend Diamond | 2024-07-11 | Monthly | 11 | 14.91% | 9.72 |
BRW | Dividend Diamond | 2024-06-11 | Monthly | 33 | 9.41% | 9.26 |
VVR | Dividend Diamond | 2024-06-18 | Monthly | 27 | 8.85% | 9.19 |
FCT | Dividend Diamond | 2024-06-03 | Monthly | 21 | 8.33% | 9.14 |
PHK | Dividend Diamond | 2024-06-13 | Monthly | 22 | 9.07% | 9.13 |
SBR | Dividend Diamond | 2024-06-17 | Monthly | 38 | 9.57% | 9.10 |
XFLT | Dividend Diamond | 2024-06-17 | Monthly | 8 | 10.49% | 9.09 |
SRV | Dividend Royal | 2024-07-16 | Monthly | 18 | 10.61% | 9.04 |
FAM | Dividend Royal | 2024-06-03 | Monthly | 20 | 8.07% | 8.98 |
RA | Dividend Diamond | 2024-06-11 | Monthly | 9 | 10.10% | 8.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0964 | 1.500 | 8.07 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0653 | 1.500 | -0.386 | -0.579 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 4.60 | 1.000 | 9.41 | 9.41 | [3 - 30] |
operatingCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
freeCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.600 | 1.000 | 3.33 | 3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.181 | 1.000 | 8.38 | 8.38 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.333 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.70 | 1.000 | 7.30 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0653 | 2.50 | -0.248 | -0.579 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
dividendYielPercentageTTM | 2.33 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 4.53 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | 2.42 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.